Osimertinib |
|
| Synonyms: N-?[2-?[[2-?(dimethylamino)?ethyl]?methylamino]?-?4-?methoxy-?5-?[[4-?(1-?methyl-?1H-?indol-?3-?yl)?-?2-?pyrimidinyl]?amino]?phenyl]?-2-?Propenamide; AZD 9291 | |
| Cat. No.: O77000 | CAS No.: 1421373-65-0 |
| MDL.: | Formula: C28H33N7O2 |
| F.W.499.61 | Purity: 99% |
| Storage: | |
|   | |
| Catalog Number: | O77000 | CAS No.: | 1421373-65-0 | |
| MDL: | Formula: | C28H33N7O2 | ||
| F.W.: | 499.61 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | |||
| Storage: | Category: | Reference Standard | ||
| Application: | AZD-9291 is a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors. | |||








